IceCure Medical Ltd. Stock-Based Compensation
IceCure Medical Ltd. (ICCM) reported Stock-Based Compensation of $1.37 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-17.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-03-17
| Period end | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|
| 2025-12-31 | $1.37M 20-F · filed 2026-03-17 | |
| 2025-06-30 | $295.00K 6-K · filed 2025-08-13 | |
| 2024-12-31 | $869.00K 20-F · filed 2026-03-17 | |
| 2024-06-30 | $410.00K 6-K · filed 2025-08-13 | |
| 2023-12-31 | $1.31M 20-F · filed 2026-03-17 | |
| 2023-06-30 | $674.00K 6-K · filed 2024-08-20 | |
| 2022-12-31 | $1.86M 20-F · filed 2025-03-27 | |
| 2022-06-30 | $885.00K 6-K · filed 2023-08-14 | |
| 2021-12-31 | $316.00K 20-F · filed 2024-04-03 | |
| 2021-06-30 | $184.00K 6-K · filed 2022-09-22 | |
| 2020-12-31 | $229.00K 20-F · filed 2023-03-29 | |
| 2019-12-31 | $372.00K 20-F/A · filed 2022-08-22 |